Large subretinal hemorrhage after intravitreal bevacizumab (Avastin ® ) for age-related macular degeneration

Author：  

Publisher： Humana Press, Inc

ISSN： 1530-4086

Source： Annals of Ophthalmology, Vol.39, Iss.1, 2007-03, pp. : 51-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 370-375

Karger

Access to resources Recommend Favorite

Natural History of Macular Subretinal Hemorrhage in Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 213, Iss. 2, 1999-01 ,pp. : 97-102

Karger

Access to resources Recommend Favorite

Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 41, Iss. 1, 2008-10 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration

By  

Case Reports in Ophthalmology, Vol. 1, Iss. 1, 2010-08 ,pp. : 36-41

Karger

Access to resources Recommend Favorite

Comparing Treatment of Neovascular Age-related Macular Degeneration with Sequential Intravitreal Avastin and Macugen Versus Intravitreal Mono-therapy–A Pilot Study

By Schmid-Kubista Katharina E.   Krebs Ilse   Ansari-Shahrezaei Siamak   Haas Paulina   Hagen Stefan   Binder Susanne  

Current Eye Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 958-963

Informa Healthcare

Access to resources Recommend Favorite